Deficiency of terminal ADP-ribose protein glycohydrolase TARG1/C6orf130 in neurodegenerative disease
about
Functions of PARylation in DNA Damage Repair PathwaysTrial watch - inhibiting PARP enzymes for anticancer therapyReaders of poly(ADP-ribose): designed to be fit for purposeIntracellular Mono-ADP-Ribosylation in Signaling and DiseaseStructure and function of the ARH family of ADP-ribosyl-acceptor hydrolasesThe role of poly(ADP-ribosyl)ation in DNA damage response and cancer chemotherapyVisualization of poly(ADP-ribose) bound to PARG reveals inherent balance between exo- and endo-glycohydrolase activitiesStructure of the sirtuin-linked macrodomain SAV0325 from Staphylococcus aureusThe role of ADP-ribosylation in regulating DNA interstrand crosslink repairDisruption of Macrodomain Protein SCO6735 Increases Antibiotic Production in Streptomyces coelicolorADP-ribosyltransferases and poly ADP-ribosylationHPF1/C4orf27 Is a PARP-1-Interacting Protein that Regulates PARP-1 ADP-Ribosylation ActivityIdentification of a Class of Protein ADP-Ribosylating Sirtuins in Microbial PathogensADP-ribosyl-acceptor hydrolase 3 regulates poly (ADP-ribose) degradation and cell death during oxidative stressSerine ADP-Ribosylation Depends on HPF1PARP-2 and PARP-3 are selectively activated by 5' phosphorylated DNA breaks through an allosteric regulatory mechanism shared with PARP-1.Family-wide analysis of poly(ADP-ribose) polymerase activityNew facets in the regulation of gene expression by ADP-ribosylation and poly(ADP-ribose) polymerases.Transition-state analysis of 2-O-acetyl-ADP-ribose hydrolysis by human macrodomain 1.The Toxin-Antitoxin System DarTG Catalyzes Reversible ADP-Ribosylation of DNA.Mice without macroH2A histone variants.The nsp3 macrodomain promotes virulence in mice with coronavirus-induced encephalitisA quantitative assay reveals ligand specificity of the DNA scaffold repair protein XRCC1 and efficient disassembly of complexes of XRCC1 and the poly(ADP-ribose) polymerase 1 by poly(ADP-ribose) glycohydrolase.Poly(ADP-ribosyl) glycohydrolase prevents the accumulation of unusual replication structures during unperturbed S phaseMolecular underpinnings of Aprataxin RNA/DNA deadenylase function and dysfunction in neurological disease.Processing of protein ADP-ribosylation by Nudix hydrolases.New players to the field of ADP-ribosylation make the final cutPoly(ADP-ribose) glycohydrolase and poly(ADP-ribose)-interacting protein Hrp38 regulate pattern formation during Drosophila eye development.Viral Macro Domains Reverse Protein ADP-Ribosylation.Poly(ADP-ribose) polymerases covalently modify strand break termini in DNA fragments in vitro.Structural Implications for Selective Targeting of PARPs.The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection.Fluorescent sensors of PARP-1 structural dynamics and allosteric regulation in response to DNA damage.ADPriboDB: The database of ADP-ribosylated proteins.PARPs and ADP-ribosylation: recent advances linking molecular functions to biological outcomes.Expanding functions of intracellular resident mono-ADP-ribosylation in cell physiology.The recognition and removal of cellular poly(ADP-ribose) signals.Poly(ADP-ribose) polymerase 1 (PARP1) in atherosclerosis: from molecular mechanisms to therapeutic implications.Poly(ADP-ribosyl)ation in regulation of chromatin structure and the DNA damage response.ADP-ribosylation: activation, recognition, and removal
P2860
Q26744796-9CCF50CD-6CC3-41D0-AC27-D6D015229D9BQ26745673-C9A67225-ABFF-4A59-B7F3-70B69025B882Q26775561-08D80DA9-27D0-41B4-B97D-0BD1C82B0C59Q26783018-194B3C77-2E09-4E02-8FF3-5C20DC56E74BQ27004584-D9E16328-193D-40ED-8637-D8BBCF300BBDQ27010084-1FB9F425-211C-4A4F-8CCC-40276EF1B57CQ27679375-9624227D-3470-4642-B62C-AA12A11C3335Q27713797-CC05979B-D887-4538-83DA-88854FE4F63CQ27727978-55DF9122-DA12-48DC-81F9-9CFBDA3F5985Q27728072-CACFA11F-97B3-4C8F-A7B5-DC97664A7D14Q28082350-F093072D-8FE1-4C8F-B718-9C133696A089Q28118267-2FF7F0E1-175E-46FD-95DE-548CB81E8AEEQ28264979-714A249E-70DB-468F-9F87-FF51E85EE71FQ28504824-7907D488-6435-4B27-BF8E-A7DB4A1C2153Q28975776-E1655F36-1F5E-4A08-A68D-47A78646901DQ33843139-D926F511-371F-42B6-93B0-DEEC686BA6BAQ34009850-9F0DAA61-57A5-4B05-A361-19F9DCD3D3F9Q34042969-1AF2DAF4-5589-470E-B03E-1646C7E01807Q34361141-642D1B06-4428-4163-A158-4297D00015E2Q34547062-57B90BF3-A5ED-4118-930C-60AB205CDDBEQ34592847-65061A31-E416-430C-B5E7-3DE46D272961Q34991394-2AE6BB92-9480-4D70-A46A-7C6C842C7BCCQ35055636-245EFD6D-D680-497E-AFA4-9A7368D5D673Q35069579-B8711B58-EE46-45F0-A37D-04BFD2B9AA85Q35562885-DD54629A-A136-44E6-AB73-7E038AA3317CQ35581139-E19AC6A1-F329-4EB6-8F7E-B9B2B693F13AQ36812791-C4C0B67C-9268-4273-9936-406E6ADCE287Q37060200-E099627B-0D0C-4A7B-9E0E-E7C5A526F2C6Q37252975-99A6E3F5-5F02-4194-9A9E-AC2125F98399Q37401119-8C2EF325-6E12-4ABC-BCC2-4D8AB8DB6340Q37405386-A2BC6815-D1ED-48C0-AF95-01E9EC3E3159Q37502927-DBB6A47C-0271-4880-A17F-E69D0DF7EE9BQ37522977-438FF4CC-5CF7-439A-A05E-3306CCB83576Q37556937-BCED4C24-5C4D-4FA6-AFD3-7FF7B195FD6EQ37661664-DF4EF51D-76CE-4E08-8F69-612F46953184Q38103617-773714AB-1AE4-42FD-8C51-13B7A15A0DDCQ38109700-DD59E330-16CA-4E04-BDD6-4C1F571CA5ECQ38134049-19116D32-8798-4400-828D-8D4C1C08B36FQ38155805-177DCA6D-1500-4517-BDBD-6235EF1CD52EQ38189514-D9260DC1-34F8-4C44-BF57-A8058A218860
P2860
Deficiency of terminal ADP-ribose protein glycohydrolase TARG1/C6orf130 in neurodegenerative disease
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Deficiency of terminal ADP-rib ...... 0 in neurodegenerative disease
@ast
Deficiency of terminal ADP-rib ...... 0 in neurodegenerative disease
@en
Deficiency of terminal ADP-rib ...... 0 in neurodegenerative disease
@en-gb
Deficiency of terminal ADP-rib ...... 0 in neurodegenerative disease
@nl
type
label
Deficiency of terminal ADP-rib ...... 0 in neurodegenerative disease
@ast
Deficiency of terminal ADP-rib ...... 0 in neurodegenerative disease
@en
Deficiency of terminal ADP-rib ...... 0 in neurodegenerative disease
@en-gb
Deficiency of terminal ADP-rib ...... 0 in neurodegenerative disease
@nl
prefLabel
Deficiency of terminal ADP-rib ...... 0 in neurodegenerative disease
@ast
Deficiency of terminal ADP-rib ...... 0 in neurodegenerative disease
@en
Deficiency of terminal ADP-rib ...... 0 in neurodegenerative disease
@en-gb
Deficiency of terminal ADP-rib ...... 0 in neurodegenerative disease
@nl
P2093
P2860
P50
P921
P3181
P356
P1433
P1476
Deficiency of terminal ADP-rib ...... 0 in neurodegenerative disease
@en
P2093
Alexander Wan
Andrew H Crosby
Barbara Golia
C Denise Appel
Dragana Ahel
Gytis Jankevicius
Gyula Timinszky
Hamid Galehdari
P2860
P304
P3181
P356
10.1038/EMBOJ.2013.51
P407
P50
P577
2013-03-12T00:00:00Z